Molecular effects of the myosin activator omecamtiv mecarbil on contractile properties of skinned myocardium lacking cardiac myosin binding protein-C
about
N-Terminus of Cardiac Myosin Essential Light Chain Modulates Myosin Step-Size.Modulating Beta-Cardiac Myosin Function at the Molecular and Tissue Levels.Cardiac Myosin Binding Protein-C Phosphorylation Modulates Myofilament Length-Dependent ActivationAblation of cardiac myosin binding protein-C disrupts the super-relaxed state of myosin in murine cardiomyocytes.Cardiac myosin binding protein-C Ser302 phosphorylation regulates cardiac β-adrenergic reserveExpert consensus document: Mitochondrial function as a therapeutic target in heart failureThe Sydney Heart Bank: improving translational research while eliminating or reducing the use of animal models of human heart disease.Heart failure drug changes the mechanoenzymology of the cardiac myosin powerstroke.Omecamtiv Mecarbil Abolishes Length-Mediated Increase in Guinea Pig Cardiac Myofiber Ca2+ Sensitivity.Omecamtiv mercabil and blebbistatin modulate cardiac contractility by perturbing the regulatory state of the myosin filament.Allosteric modulation of cardiac myosin dynamics by omecamtiv mecarbil.Omecamtiv Mecarbil Enhances the Duty Ratio of Human β-Cardiac Myosin Resulting in Increased Calcium Sensitivity and Slowed Force Development in Cardiac Muscle.Positive cardiac inotrope omecamtiv mecarbil activates muscle despite suppressing the myosin working strokeImpact of the Myosin Modulator Mavacamten on Force Generation and Cross-Bridge Behavior in a Murine Model of Hypercontractility
P2860
Q30701531-2F898893-5FF1-48ED-9C02-F8B73C225BC6Q34549974-CCF8514C-3154-44DD-956F-AB09BE91CC05Q36579173-F573268F-529F-4255-BD42-BB612C6206FBQ36885406-AF0BF10E-5064-4542-BDE2-0DE0A07B0BDFQ37693685-EF112C11-8D56-47B8-A79A-5648F8BBA374Q37699474-76706815-C668-4313-BC41-4CCA3D88F488Q41579484-CAD3A1A1-8458-41A7-96C4-CD5F01B86AEBQ41814795-D99E4D2B-DBA7-48DE-90F4-D7D6B7A7A00CQ46650156-809DD62F-8E9E-46A3-91C7-F278AE9BD2CCQ47102056-D3A5AD2B-CD88-47D0-803B-C24B3A4A00ECQ47137936-9A06D9E9-13E9-4615-B581-801B6063AF35Q48049889-433E8B38-4B23-4478-92DA-1E18FBCDD365Q57153298-D9AF6F55-56E7-414F-BE04-3F1A3B4BFC42Q58127428-09F49A8C-3611-464F-8617-622C69A0DC61
P2860
Molecular effects of the myosin activator omecamtiv mecarbil on contractile properties of skinned myocardium lacking cardiac myosin binding protein-C
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Molecular effects of the myosi ...... rdiac myosin binding protein-C
@ast
Molecular effects of the myosi ...... rdiac myosin binding protein-C
@en
type
label
Molecular effects of the myosi ...... rdiac myosin binding protein-C
@ast
Molecular effects of the myosi ...... rdiac myosin binding protein-C
@en
prefLabel
Molecular effects of the myosi ...... rdiac myosin binding protein-C
@ast
Molecular effects of the myosi ...... rdiac myosin binding protein-C
@en
P2093
P2860
P1476
Molecular effects of the myosi ...... rdiac myosin binding protein-C
@en
P2093
Cristobal G dos Remedios
Julian E Stelzer
Kenneth S Gresham
Ranganath Mamidi
P2860
P304
P356
10.1016/J.YJMCC.2015.06.011
P577
2015-06-20T00:00:00Z